Trial site
Zvezdara University Medical Center
- 4running trials
- 6closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis5 trials
- Crohn's disease2 trials
- Chronic kidney disease1 trial
- High blood pressure1 trial
- Macular degeneration1 trial
- Osteoporosis1 trial
- Phase
- Phase 35 trials
- Phase 23 trials
- Phase 2/32 trials
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)2 trials
- Alfasigma S.p.A.1 trial
- Enzene Biosciences Ltd.1 trial
- InDex Pharmaceuticals1 trial
- and 3 more
Running trials
Recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Completed
A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®
Terminated
Terminated
Completed
A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD
Completed
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Site data: ClinicalTrials.govUpdated 13 Nov 2026